The Competent Cells Market is Predict to reach USD 3.7 Billion by 2031, at a CAGR of 7.9%

Competent Cells Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Competent Cells Market size is expected to reach $3.7 billion by 2031, rising at a market growth of 7.9% CAGR during the forecast period.

Competent cells are bacterial cells, typically Escherichia coli (E. coli) or other bacterial strains, that have been genetically altered to be capable of taking up foreign DNA molecules from their surrounding environment. This ability makes them valuable tools in molecular biology, biotechnology, genetic engineering, and various research applications.

The Chemically Competent Cells segment is registering a CAGR of 7.3 % during the forecast period. Chemically competent cells offer versatility in applications across different types of genetic manipulations. They can efficiently uptake exogenous DNA through chemical treatments, making them suitable for various molecular biology techniques such as cloning, transformation, and recombinant protein expression.

The Cloning segment led the Global Competent Cells Market by Application in 2023; thereby, achieving a market value of $1.5 billion by 2031. Cloning is a fundamental technique in molecular biology used to replicate DNA fragments, genes, or entire genomes. Competent cells play a critical role in this process by serving as hosts for introducing and replicating recombinant DNA molecules.

The Pharmaceutical & Biotechnology Companies is growing at a CAGR of 7.4 % during the forecast period. Competent cells are essential tools in the development of new drugs, biopharmaceuticals, and vaccines. They are used for cloning genes, producing recombinant proteins, and engineering microorganisms to produce therapeutic compounds.

Full Report: https://www.kbvresearch.com/competent-cells-market/

The North America region dominated the Global Competent Cells Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1.3 billion by 2031. The Europe region is anticipated to grow at a CAGR of 7.5% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 8.5% during (2024 - 2031).

List of Key Companies Profiled

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Promega Corporation
• New England Biolabs, Inc.
• Qiagen N.V
• Hoffmann-La Roche Ltd.
• Takara Bio Inc. (Takara Holdings Inc.)
• Lonza Group Ltd. (Capsugel)

Competent Cells Market Report Segmentation

By Type

• Chemically Competent Cells
• Electrocompetent Cells
• Ultracompetent Cells

By Application

• Cloning
• Protein Expression
• Mutagenesis
• Others

By End-Use

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Related Reports:

North America Competent Cells Market Size | Share 2031

• July-2024
• 112 Pages

LAMEA Competent Cells Market Size, Share | Forecast 2031

• July-2024
• 123 Pages

Europe Competent Cells Market Size & Growth Report| 2031

• July-2024
• 122 Pages

Asia Pacific Competent Cells Market Size & Analysis | 2031

• July-2024
• 124 Pages